Stay updated on Rilzabrutinib for CSU: H1 Resistant - Clinical Trial

Sign up to get notified when there's something new on the Rilzabrutinib for CSU: H1 Resistant - Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Rilzabrutinib for CSU: H1 Resistant - Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Revision v3.5.2 was added and revision v3.5.0 was removed.
    Difference
    0.0%
    Check dated 2026-04-19T13:43:33.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    32 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0 and removed Revision: v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-20T20:12:06.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    Added a revision notice: Revision: v3.4.3, and removed Revision: v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-06T17:52:12.000Z thumbnail image
  6. Check
    67 days ago
    Change Detected
    Summary
    Revision from v3.4.1 to v3.4.2 appears to be a minor site version update with no changes to study content or page structure. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-13T12:33:37.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    Revision: v3.4.1 is now displayed on the page, replacing Revision: v3.4.0.
    Difference
    0.0%
    Check dated 2026-02-05T23:48:30.000Z thumbnail image
  8. Check
    97 days ago
    Change Detected
    Summary
    Minor version update: Revision v3.3.4 was added and Revision v3.3.3 was removed. It does not affect the study details or how users interact with the page.
    Difference
    0.0%
    Check dated 2026-01-15T05:12:47.000Z thumbnail image

Stay in the know with updates to Rilzabrutinib for CSU: H1 Resistant - Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Rilzabrutinib for CSU: H1 Resistant - Clinical Trial page.